Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Centers for Disease Control & Prevention

Division of US Department of Health and Human Services
www.cdc.gov

Latest From Centers for Disease Control & Prevention

Lyme Disease Vaccine Pushes Valneva To US Listing

Thomas Lingelbach talks to Scrip about Valneva’s plans for a US IPO to fund Phase III studies of its lead Lyme disease vaccine.

Infectious Diseases Vaccines

New Trends In R&D Partnering: Biopharma’s Bet On The US Veterans Administration

The US Veterans Administration is attracting more interest from drugmakers seeking to grow their foothold in the lucrative – but scientifically challenging – market for CNS disorders. The allure comes from VA’s strong analytics and data crunching capabilities as well as its investigatory and trial management expertise in high-profile areas like traumatic brain injury, post-traumatic stress and major depression.

Research and Development Strategies Innovation

Panel: Broaden Opioids Risk Plans, Require Prescriber Training

An FDA panel of expert advisers unanimously agreed the risk plans for opioids need to be significantly changed – with most calling for them to cover immediate-release products, rather than just the extended-release and long-acting drugs. Most on the committee also insisted prescriber training should be mandatory, rather than voluntary.

Policy Advisory Committees

US Patient Monitoring Devices Market Forecast To Grow $500 Million By 2019 Despite Pricing Pressures, Spending Slowdown

Despite slowdowns in capital equipment spending and strong pricing pressures, the US patient monitoring device market will grow by over $500 million between 2014 and 2019, reaching more than $2.5 billion by 2019 – a CAGR of almost 5%. Several factors are driving growth in this market, including the need for seamless solutions that can provide monitoring from hospital to home, and the growing adoption of portable and wearable technologies.

Medical Device
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register